Condition: Hepatitis B · Vaccination; Infection · Preventable Disease, Vaccine · Sponsor: National Taiwan University Hospital
This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer\<10 mIU/mL) need to take.
This description comes directly from the study's public registry record.
CHYI-FENG JAN, MD, PHD · +886-2-23123456 · jcf036@gmail.com
Always discuss trial participation with your own doctor first.
| Family Medicine, NTUH | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04970836